ViaCyte gets funding for potential diabetes cure

5089f3386cbd3.preview-620

ViaCyte is developing a drug delivery system that enables implanted pancreatic progenitor cells to survive and differentiate into functioning insulin-producing islet cells.

Read more

Posted in Drugs Other News